Semaglutide 10mg

Semaglutide is a synthetic peptide analogue of the human glucagon-like peptide-1 (GLP-1), composed of 31 amino acids. It is structurally modified to resist enzymatic degradation, thereby enhancing its stability and extending its half-life. Initially developed for metabolic research, Semaglutide mimics the action of endogenous GLP-1, a hormone involved in glucose regulation, insulin secretion, and appetite control.

In research models, Semaglutide has demonstrated potent activity in reducing blood glucose levels by enhancing insulin release in a glucose-dependent manner and suppressing glucagon secretion. Additionally, studies have shown that Semaglutide slows gastric emptying and promotes satiety, leading to a reduction in food intake and body weight.

Beyond metabolic regulation, ongoing research investigates Semaglutide’s potential neuroprotective and cardioprotective effects, including its impact on inflammatory markers and endothelial function. Its extended duration of action makes it an attractive subject for long-term therapeutic applications in chronic metabolic disorders.

Semaglutide’s unique pharmacokinetic properties and its broad biological activity profile position it as a key peptide of interest in endocrinology, obesity, and diabetes research.